231 related articles for article (PubMed ID: 11829129)
21. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
[TBL] [Abstract][Full Text] [Related]
22. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
23. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
Ghanbarzadeh S; Arami S; Pourmoazzen Z; Khorrami A
Colloids Surf B Biointerfaces; 2014 Mar; 115():323-30. PubMed ID: 24394948
[TBL] [Abstract][Full Text] [Related]
24. Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin.
Evjen TJ; Hagtvet E; Nilssen EA; Brandl M; Fossheim SL
Eur J Pharm Sci; 2011 Jul; 43(4):318-24. PubMed ID: 21620968
[TBL] [Abstract][Full Text] [Related]
25. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
[TBL] [Abstract][Full Text] [Related]
26. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
[TBL] [Abstract][Full Text] [Related]
27. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
28. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
29. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.
Vila-Caballer M; Codolo G; Munari F; Malfanti A; Fassan M; Rugge M; Balasso A; de Bernard M; Salmaso S
J Control Release; 2016 Sep; 238():31-42. PubMed ID: 27444816
[TBL] [Abstract][Full Text] [Related]
30. A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
Zhai L; Luo C; Gao H; Du S; Shi J; Wang F
Int J Nanomedicine; 2021; 16():3185-3199. PubMed ID: 34007173
[TBL] [Abstract][Full Text] [Related]
31. On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes.
Simões S; Slepushkin V; Düzgünes N; Pedroso de Lima MC
Biochim Biophys Acta; 2001 Nov; 1515(1):23-37. PubMed ID: 11597349
[TBL] [Abstract][Full Text] [Related]
32. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
33. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.
Mahmoudzadeh M; Magarkar A; Koivuniemi A; Róg T; Bunker A
Mol Pharm; 2021 Jul; 18(7):2612-2621. PubMed ID: 34096310
[TBL] [Abstract][Full Text] [Related]
35. On the formulation of pH-sensitive liposomes with long circulation times.
Simões S; Moreira JN; Fonseca C; Düzgüneş N; de Lima MC
Adv Drug Deliv Rev; 2004 Apr; 56(7):947-65. PubMed ID: 15066754
[TBL] [Abstract][Full Text] [Related]
36. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
[TBL] [Abstract][Full Text] [Related]
37. A novel pH-sensitive liposome formulation containing oleyl alcohol.
Sudimack JJ; Guo W; Tjarks W; Lee RJ
Biochim Biophys Acta; 2002 Aug; 1564(1):31-7. PubMed ID: 12100993
[TBL] [Abstract][Full Text] [Related]
38. Interactions of liposome bilayers composed of 1,2-diacyl-3-succinylglycerol with protons and divalent cations.
Tari AM; Fuller N; Boni LT; Collins D; Rand P; Huang L
Biochim Biophys Acta; 1994 Jun; 1192(2):253-62. PubMed ID: 8018706
[TBL] [Abstract][Full Text] [Related]
39. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
40. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.
Zhang X; Xie Y; Jin Y; Hou X; Ye L; Lou J
Drug Deliv; 2004; 11(5):301-9. PubMed ID: 15742555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
